Clinico-biological Study/Characterization of Rhabdomyosarcoma in Adolescents and Young Adults, 15-25-year-old Patients

Active, not recruitingOBSERVATIONAL
Enrollment

113

Participants

Timeline

Start Date

February 2, 2018

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Rhabdomyosarcoma
Trial Locations (20)

13385

MARSEILLE La Timone, Marseille

29609

Brest Chu, Brest

31059

TOULOUSE Institut Claudius Regaud, Toulouse

33076

BORDEAUX Bergonié, Bordeaux

34295

Montpellier Chu, Montpellier

34298

MONTPELLIER ICM Val d'Aurelle, Montpellier

37044

TOURS CHU-Bretonneau/Hôp G de Clocheville, Tours

44093

Nantes Chu, Nantes

54035

CHU de Nancy, Nancy

54519

NANCY Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy

59020

LILLE Centre Oscar Lambret/ CHRU de Lille, Lille

67098

Strasbourg Chru, Strasbourg

69373

LYON- Bérard, Lyon

75005

PARIS Curie, Paris

86000

Poitiers Chu, Poitiers

Unknown

Bordeaux Chu, Bordeaux

NANTES Institut de Cancérologie de l'Ouest, Nantes

Villejuif Igr, Villejuif

06003

NICE CHU, Nice

06189

NICE Centre Antoine Lacassagne, Nice

All Listed Sponsors
collaborator

Centre Leon Berard

OTHER

collaborator

Société Française de lutte contre les Cancers et les leucémies de l'Enfant et l'adolescent

UNKNOWN

collaborator

French Sarcoma Group

OTHER

collaborator

Ligue contre le cancer, France

OTHER

lead

Centre Oscar Lambret

OTHER

NCT03462888 - Clinico-biological Study/Characterization of Rhabdomyosarcoma in Adolescents and Young Adults, 15-25-year-old Patients | Biotech Hunter | Biotech Hunter